Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update Aug 14, 2023
UPDATE -- Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update May 4, 2023
Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update May 4, 2023
Cellectar Biosciences Reports Complete Response in a Relapsed/Refractory CNS Lymphoma Patient Feb 28, 2023
Cellectar Biosciences Announces Presentation of Data on CLR 12120 Series of Targeted Alpha-Emitting Therapies at the 13th Annual World ADC Conference Nov 21, 2022
